"Headache Syndromes for MRCP Part 1

TL;DR

Headache Syndromes: Cluster, Hemicrania, IIH are frequently tested neurological topics in MRCP Part 1, especially in questions assessing pattern recognition and first-line treatment. Cluster headache presents with severe unilateral orbital pain and autonomic symptoms, hemicrania responds dramatically to indometacin, and idiopathic intracranial hypertension (IIH) causes raised intracranial pressure with papilloedema. Learning these classic clinical patterns allows candidates to answer many neurology MCQs quickly and confidently.

Why this matters

Neurology questions in MRCP Part 1 often reward candidates who can rapidly identify classical clinical presentations.

For headache syndromes, examiners commonly test whether you can:

• Recognise hallmark headache patterns

• Identify autonomic symptoms associated with trigeminal autonomic cephalalgias

• Select the correct first-line acute therapy

• Distinguish primary headache disorders from raised intracranial pressure

• Recognise vision-threatening complications

Cluster headache, hemicrania syndromes, and IIH are particularly suitable for MCQs because they contain distinct diagnostic clues that guide the correct answer.

Core Sections

1. Cluster Headache

Cluster headache is part of the trigeminal autonomic cephalalgia group and is characterised by severe unilateral attacks associated with cranial autonomic symptoms.

Key Clinical Features

Typical features tested in MRCP include:

• Severe unilateral orbital or temporal pain

• Short attack duration (15–180 minutes)

• Occurrence in clusters lasting weeks

• Associated autonomic symptoms such as:

  • Lacrimation

  • Conjunctival injection

  • Nasal congestion

  • Ptosis or miosis

Patients often appear agitated or restless, which contrasts with migraine sufferers who prefer lying still.

Cluster headaches frequently occur at the same time each day, suggesting hypothalamic involvement.

Acute Treatment

First-line therapy includes:

• High-flow 100% oxygen

• Subcutaneous sumatriptan

These treatments are commonly tested in MRCP MCQs.

Preventive Therapy

The most frequently tested preventive medication is:

• Verapamil

Other options may include lithium or corticosteroids in specialist settings.

Authoritative classification and guidance can be found in the International Headache Society classificationhttps://ichd-3.org/

2. Hemicrania Syndromes

Hemicrania syndromes include two primary disorders:

1. Paroxysmal hemicrania

2. Hemicrania continua

Both conditions fall within trigeminal autonomic cephalalgias.

The Key Exam Clue

The single most important fact for MRCP candidates is:

Hemicrania responds completely to indometacin.

This response is so characteristic that it is often considered diagnostic.

Paroxysmal Hemicrania

Typical features include:

• Unilateral headache

• Short attacks (2–30 minutes)

• High attack frequency (often many per day)

• Associated autonomic features similar to cluster headache

However, attacks are usually shorter and more frequent than cluster headaches.

Hemicrania Continua

This condition presents differently.

Typical features include:

• Continuous unilateral headache

• Superimposed exacerbations

• Dramatic response to indometacin

MRCP exam questions often describe a patient with persistent unilateral headache relieved by indometacin, pointing directly to this diagnosis.

3. Idiopathic Intracranial Hypertension (IIH)

Idiopathic intracranial hypertension (IIH), previously known as pseudotumour cerebri, is a condition of raised intracranial pressure without structural brain pathology.

The condition is important because it may cause permanent visual loss if untreated.

Clinical guidance can be found in NICE resourceshttps://cks.nice.org.uk/topics/headache/

Risk Factors

The typical patient profile tested in MRCP includes:

• Young obese woman

• Recent weight gain

• Certain medications

Drugs associated with IIH include:

• Tetracycline antibiotics

• Vitamin A derivatives (e.g., isotretinoin)

• Growth hormone

Clinical Features

Common symptoms include:

• Persistent headache

• Transient visual obscurations

• Pulsatile tinnitus

• Diplopia due to sixth nerve palsy

The most important clinical sign is:

Papilloedema

Diagnostic Approach

Diagnosis involves exclusion of structural causes.

Typical steps include:

1. Brain imaging (MRI or CT) – usually normal

2. Lumbar puncture – raised opening pressure

CSF composition is typically normal.

Treatment

Initial management focuses on reducing intracranial pressure.

First-line therapy includes:

• Weight loss

• Acetazolamide

Surgical options such as optic nerve sheath fenestration or CSF shunting may be considered if vision deteriorates.

Comparison Table: Key MRCP Differences

Feature	Cluster Headache	Hemicrania Syndromes	Idiopathic Intracranial Hypertension
Typical patient	Middle-aged male	Often female	Young obese female
Pain pattern	Severe unilateral attacks	Continuous or frequent unilateral pain	Diffuse headache
Attack duration	15–180 minutes	Minutes or continuous	Persistent
Autonomic symptoms	Common	Common	Usually absent
Diagnostic clue	Occurs in clusters	Response to indometacin	Papilloedema
First-line treatment	Oxygen or sumatriptan	Indometacin	Acetazolamide

Practical Example / Mini-Case

MRCP-style question

A 29-year-old woman presents with daily headaches and brief episodes of visual blurring lasting several seconds. She has recently gained weight. Examination reveals bilateral papilloedema. Brain MRI is normal.

What is the most appropriate initial treatment?

A. SumatriptanB. IndometacinC. AcetazolamideD. VerapamilE. Propranolol

Answer: C — Acetazolamide

Explanation

This presentation is characteristic of idiopathic intracranial hypertension:

• Young obese woman

• Headache with transient visual symptoms

• Papilloedema

• Normal brain imaging

The recommended first-line therapy is acetazolamide, which reduces CSF production.

You can practise similar exam-style questions using Free MRCP MCQs or evaluate exam readiness with a Start a mock test.

Practical Study-Tip Checklist

Before sitting the exam, ensure you can recall the following:

1. Cluster headache attack duration (15–180 minutes)

2. Oxygen and sumatriptan for acute cluster treatment

3. Verapamil as preventive therapy

4. Indometacin response in hemicrania

5. Young obese female profile in IIH

6. Papilloedema as a key sign of raised intracranial pressure

7. Acetazolamide as first-line treatment

8. Drug triggers of IIH (tetracyclines and vitamin A derivatives)

Common Pitfalls (Exam Traps)

• Confusing cluster headache with migraine

• Forgetting oxygen therapy for cluster attacks

• Missing the indometacin diagnostic response

• Ignoring papilloedema as a sign of raised intracranial pressure

• Assuming normal imaging excludes IIH

FAQs

What differentiates cluster headache from migraine?

Cluster headache causes severe unilateral orbital pain with autonomic symptoms and agitation. Migraine typically involves throbbing headache with photophobia, nausea, and a preference for resting quietly.

Why is indometacin important in hemicrania?

A complete response to indometacin is highly characteristic of hemicrania syndromes and is frequently used as a diagnostic clue in exam questions.

Who is most at risk of idiopathic intracranial hypertension?

IIH most commonly affects young obese women, particularly those with recent weight gain or exposure to medications such as tetracyclines or vitamin A derivatives.

What is the first-line treatment for cluster headache?

Acute cluster headache attacks are treated with high-flow oxygen or subcutaneous sumatriptan, while verapamil is used for prevention.

Why must IIH be recognised early?

Untreated IIH may lead to progressive optic nerve damage and permanent vision loss, making early diagnosis and treatment essential.

Ready to start?

If you are preparing for MRCP Part 1, mastering high-yield neurology topics such as headache syndromes can significantly improve your exam performance.

Start by reviewing the full syllabus in the MRCP Part 1 overview, practise with Free MRCP MCQs, and assess your readiness through a Start a mock test.

Consistent practice and pattern recognition remain the most reliable strategies for success.

Sources

MRCP(UK) Examination Blueprinthttps://www.mrcpuk.org/mrcpuk-examinations

International Classification of Headache Disorders (ICHD-3)https://ichd-3.org/

NICE Clinical Knowledge Summary: Headachehttps://cks.nice.org.uk/topics/headache/

British Association for the Study of Headache